000061475 001__ 61475
000061475 005__ 20190220220209.0
000061475 0247_ $$2doi$$a10.1056/NEJMc1308259
000061475 0248_ $$2sideral$$a83195
000061475 037__ $$aART-2013-83195
000061475 041__ $$aeng
000061475 100__ $$aGrzybowski, A.
000061475 245__ $$aAntithrombotic therapy and invasive procedures [5]
000061475 260__ $$c2013
000061475 5060_ $$aAccess copy available to the general public$$fUnrestricted
000061475 5203_ $$aTo the Editor: 
Baron et al. (May 30 issue) make important  suggestions  in  their  review  article; however,  we  propose  that  quantitative  assessment  of  iatrogenic  bleeding  hazards  must  be considered as well as thrombosis prevention. Although CHA2DS2–VASc scoring for atrial fibrillation is mentioned, the Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score for bleeding has also been validated. Both scores calculate  estimated  annual  risks  and  benefits  and hence can guide future therapy...
000061475 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000061475 590__ $$a54.42$$b2013
000061475 591__ $$aMEDICINE, GENERAL & INTERNAL$$b1 / 155 = 0.006$$c2013$$dQ1$$eT1
000061475 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/publishedVersion
000061475 700__ $$0(orcid)0000-0001-9876-5850$$aAscaso, F.J.$$uUniversidad de Zaragoza
000061475 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDepartamento de Cirugía, Ginecología y Obstetricia$$cOftalmología
000061475 773__ $$g369, 11 (2013), 1077-1080$$pN. Engl. j. med.$$tNEW ENGLAND JOURNAL OF MEDICINE$$x0028-4793
000061475 8564_ $$s322823$$uhttps://zaguan.unizar.es/record/61475/files/texto_completo.pdf$$yVersión publicada
000061475 8564_ $$s109621$$uhttps://zaguan.unizar.es/record/61475/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000061475 909CO $$ooai:zaguan.unizar.es:61475$$particulos$$pdriver
000061475 951__ $$a2017-06-12-09:39:12
000061475 980__ $$aARTICLE